Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Media
  • Trading Ideas

JetBlue, Crowdstrike Get CNBC Fast Money Mentions, With This Stock Popping 0.94%

By AJ Fabino
August 4, 2:18 PM
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

CRWD

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Movers
  • News
  • Trading Ideas

Wrangler, Lee Parent Posts Mixed Q2 Earnings

By Shivani Kumaresan
August 4, 1:54 PM
Kontoor Brands Inc (NYSE:KTB) reported second-quarter FY22 sales growth of 25.1% year-on-year to $614 million, missing the consensus of $618.20 million.…

KTB

Read More
2 minute read
  • Earnings
  • Entertainment
  • General
  • Hot
  • Markets
  • Media
  • News
  • Small Cap
  • Trading Ideas

Is The ‘Pounce’ Happening Today? Here’s What To Expect For AMC’s Earnings

By AJ Fabino
August 4, 1:53 PM
AMC Entertainment Holdings Inc (NYSE: AMC) is set to deliver its second-quarter earnings report on Thursday after the closing bell.

AMC

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition

By Vandana Singh
August 4, 1:47 PM
Pfizer Inc (NYSE:PFE) announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM of PF-07265803, indicated…

PFE

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Movers
  • News
  • Trading Ideas

Crocs Shares Drop On Gloomy Outlook; Q2 Earnings Top Estimates

By Shivani Kumaresan
August 4, 1:17 PM
Crocs Inc (NASDAQ:CROX) reported second-quarter FY22 sales growth of 50.5% year-on-year to $964.58 million, beating the consensus of $937.44 million. Wholesale…

CROX

Read More
3 minute read
  • General
  • Movers
  • News
  • Politics
  • Small Cap
  • Social Media
  • Trading Ideas

Donald Trump’s Opinions Will Soon Be Available To Android Users: How To Get Truth Social

By Chris Katje
August 4, 1:00 PM
Social media platform Truth Social is one of the few places left for former President Donald Trump to share his thoughts and opinions. Here’s a look at how the company could soon be expanding its reach.

AAPL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Novavax Starts Late-Stage COVID-19 Vaccine Study In Children Below 11 Years

By Vandana Singh
August 4, 12:44 PM
Novavax Inc (NASDAQ:NVAX) has initiated its Phase 2b/3 Hummingbird trial to evaluate the safety, effectiveness, and efficacy of two doses of…

NVAX

Read More
1 minute read
  • Biotech
  • General
  • Health Care

Rain Therapeutics Concludes Enrolment In Late-Stage Tissue Cancer Study, Expects Topline Data In H1 2023

By Ragothaman Srinivasan
August 4, 12:37 PM
Rain Therapeutics (NASDAQ: RAIN) has completed patient enrolment in its Phase 3 MANTRA trial of its lead asset, milademetan for well-differentiated / dedifferentiated (WD/DD) liposarcoma (LPS).

RAIN

Read More
2 minute read
  • General
  • Markets
  • News
  • Penny Stocks
  • Real Estate
  • Small Cap

So, Are We In A Recession? Mortgage Rates Drop Below 5% For First Time Since Spring

By AJ Fabino
August 4, 12:31 PM
For the first time since April, purchase mortgage rates dropped below the 5% level, reflecting the Federal Reserve’s monetary policy that has led the U.S economy to a “technical recession.”

FMCC

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Zoetis’s Clocks Mixed Q2 Earnings, Lowers FY22 Profit Outlook

By Vandana Singh
August 4, 12:23 PM
Zoetis Inc (NYSE: ZTS) has reported Q2 FY22 revenue of $2.05 billion, an increase of 5% Y/Y, almost in line with…

ZTS

Posts pagination

Previous 1 … 2,259 2,260 2,261 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service